IPO4U — Indian IPO GMP & Intelligence Platform
Quick Jump
Use ↑ ↓ to navigate · Enter to openEsc to close
Open IPOs
MainboardNSE/BSEClosed5 min read11 sections

Crystal Crop Protection IPO Review

Independent research breakdown covering business fundamentals, financial trajectory, valuation context, and key risk factors.

Full IPO Details

Issue Size

₹455.49 Cr

OFS: ₹100.71 Cr

Price Band

₹259 - ₹272

Face value ₹10

Issue Dates

18 - 20 Nov 2026

2026

Lot Size

55 shares

Mainboard

Min. Investment

₹14,960

1 lot at upper band

Latest GMP

Not Active

Unofficial indicator

Executive Summary

Subscription Verdict & Summary

Editorial Research Verdict

Crystal Crop Protection presents a fundamentally sound, integrated agrochemical-seeds play with demonstrated growth (FY24-26 revenue CAGR ~18%, PAT CAGR ~29%), strong IP moat (63 PVPs), and deep distribution. The fresh issue dominates (78%), funding expansion.

However, the IPO valuation is indeterminate without the price band. Debt is moderate but rising.

Sector cyclicality, monsoon dependency, and regulatory timelines are persistent risks. Retail investors with a 3-5 year horizon and comfort with agri-cyclicals may find the business model compelling, but should await price band for valuation assessment and compare with listed peers’ P/E and EV/EBITDA multiples before subscribing.

Balanced Assessment · Bull Case vs. Watchouts

Key Strengths & Risk Factors

Key Investment Strengths

6 pts
  • 01.Key strengths include a fully integrated R&D-to-distribution model, 63 PVP registrations protecting germplasm, 275+ hybrid SKUs across three crop categories, and an innovation index of 24.62% signalling active pipeline replenishment.
  • 02.The pan-India network of 14,717 distributors and 36 depots ensures deep rural reach.
  • 03.Backward integration in manufacturing insulates against supply shocks.
  • 04.MNC R&D collaborations bring global technology access.
  • 05.Consistent revenue and PAT growth over FY24-FY26 demonstrates execution capability.
  • 06.Promoter skin-in-the-game with three-decade track record adds credibility.

Key Risk Factors

7 pts
  • 01.Material risks include high working capital intensity typical of agrochemicals (inventory + receivables), dependence on monsoon for seasonal demand, and raw material price volatility for technical-grade intermediates.
  • 02.Regulatory risk: new product registrations (CIB&RC) can face delays.
  • 03.Debt at ₹952 crore (June 2026) requires servicing; any margin compression could stress coverage.
  • 04.OFS component (22%) signals partial promoter exit.
  • 05.Customer concentration not disclosed but distributor dependence is high.
  • 06.Forex exposure on imported technicals unhedged per provided data.
  • 07.Valuation risk: price band unknown.
01.

Company Overview

Crystal Crop Protection is a 1994-incorporated, promoter-led crop solutions company operating an integrated model across agrochemicals and seeds. It manufactures herbicides, fungicides, insecticides, and a natural solutions range including bio-stimulants and micronutrients.

Its seeds vertical covers field crops, vegetables, and marigold with 275+ hybrids and 63 PVP registrations as of June 2026. The company serves Indian farmers through 14,717 distributors and 36 distribution centres across 23 states and four union territories.

R&D collaborations with multinational firms support product development tailored to local agronomy.

02.

Business Model

Revenue is derived from two primary streams: crop protection chemicals and seeds, supplemented by natural crop solutions. The model is fully backward-integrated — spanning R&D, seed breeding, manufacturing, and last-mile distribution — reducing external dependency.

Customers are primarily small and marginal farmers accessed via a dense network of independent distributors. No single distributor or customer concentration risk is disclosed.

Operating leverage depends on monsoon patterns, raw material price cycles (especially technical-grade agrochemical intermediates), and timely regulatory approvals for new registrations.

03.

Industry Context

India’s agrochemical and seed industry is driven by rising farm mechanisation, government push for higher yields, and growing awareness of crop protection. The market is fragmented with strong MNC presence (Bayer, Syngenta, Corteva) and domestic peers like PI Industries, Rallis India, Dhanuka Agritech, and seed players such as Kaveri Seed Company and Nath Bio-Genes.

Crystal’s integrated positioning across both chemicals and seeds differentiates it from pure-play peers. Growth opportunities lie in bio-solutions adoption and hybrid seed penetration, while competitive pricing pressure and regulatory delays remain sector-wide headwinds.

04.

Issue Details & Capital Structure

The IPO opens on November 18, 2026 and closes on November 20, 2026 on the NSE and BSE mainboard. Total issue size is ₹455.49 crore, comprising a fresh issue of ₹354.77 crore (77.9%) and an offer for sale of ₹100.71 crore (22.1%).

Fresh issue proceeds will fund general corporate purposes and business expansion; OFS proceeds go to selling shareholders. Price band and lot size are yet to be announced.

Retail investors should monitor the RHP for final price discovery and minimum application value.

05.

Bidding Schedule & Lot Sizes

Bidding period: November 18–20, 2026. Basis of allotment expected around November 25, 2026 (T+5).

Demat credit of shares by November 27, 2026. Listing tentatively November 28, 2026 (T+3 post-allotment) on NSE and BSE.

Minimum retail lot size and investment amount will be finalised with the price band announcement. Retail investors should ensure UPI mandate readiness and monitor the RHP for exact lot size, price band, and anchor investor allocation details.

06.

Financial Performance & Margins

Consolidated total income grew from ₹2,271.71 crore (FY24) to ₹3,180.98 crore (FY26), a CAGR of ~18.4%. PAT rose from ₹87.24 crore to ₹144.91 crore (CAGR ~29%), with FY26 PAT margin at 4.55%.

EBITDA expanded from ₹209.06 crore to ₹456.23 crore (FY26 margin 14.3%). Total borrowings stood at ₹820.04 crore (FY26) versus net worth of ₹2,039.76 crore, implying a debt-to-equity of ~0.4x.

Reserves grew steadily to ₹1,386.12 crore. Q1 FY27 (June 2026) shows annualised revenue run-rate of ~₹4,800 crore and PAT of ₹135.78 crore, indicating seasonal front-loading.

Company Financials (Restated Consolidated)Figures in Amount in ₹ Crore
Period Ended30 Jun 202631 Mar 202631 Mar 202531 Mar 2024
Assets4,498.273,927.243,538.432,541.92
Total Income1,209.213,180.982,731.942,271.71
Profit After Tax135.78144.91118.3987.24
EBITDA241.78456.23315.28209.06
NET Worth2,039.761,600.101,488.39
Reserves and Surplus1,524.851,386.121,296.901,197.23
Total Borrowing952.02820.04947.02577.29
07.

Peer Valuation & Industry Comparison

Crystal competes with diversified agrochemical players like PI Industries (strong CSM exports), Rallis India (Tata group, domestic focus), and Dhanuka Agritech (distribution strength). In seeds, peers include Kaveri Seed Company (field crops leader) and Nath Bio-Genes (vegetable seeds).

Crystal’s dual chemicals-seeds integration is relatively unique among listed peers. Its FY26 revenue of ₹3,181 crore places it in the mid-tier; PI Industries and Rallis are larger.

Valuation comparison will depend on the IPO price band. Crystal’s 14.3% EBITDA margin is competitive but below export-oriented peers with higher value-add.

08.

Promoters & Corporate Governance

Promoters are Nand Kishore Aggarwal, Ankur Aggarwal, Komal Aggarwal, and the Ankur Aggarwal KNK Family Trust — a family group with over three decades of operational history since 1994. Ankur Aggarwal leads the second generation.

The board includes experienced professionals, though detailed independent director profiles and committee compositions are not in the provided data. Promoter holding pre-issue and post-issue percentages are not disclosed here.

Governance track record appears stable with no reported regulatory actions, but investors should verify related-party transactions and board independence in the full prospectus.

This review is published strictly for informational and research purposes and does not constitute SEBI-registered investment advice. Always verify issue terms against the official Red Herring Prospectus (RHP) and consult a certified financial advisor before applying.